Author

Venu Venkatarame Gowda Saralamma

University of MiamiORCID 0000-0002-0844-1009Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 4 Approach:experimental assay· 4 Research Focus:cancer & tumor microenvironment· 3 Research Focus:cell type annotation· 3 Organism:human· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Assay:clinical cohort / trial· 1

Frequent Co-Authors

Jonathan Harry SchatziD· 4 shared Daniel Bilbao CortesiD· 3 shared Francesco MauraiD· 3 shared Abdessamad Alaoui YoussfiiD· 2 shared Austin Daniel NewsamiD· 2 shared Caroline Alice CoughliniD· 2 shared Dhanvantri ChahariD· 2 shared Nikolai S. FattakhoviD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Jonathan Harry SchatzORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BCL10 Gain-of-Function Impairs Germinal Center Participation by Naive B Cells and Cooperates with BCL6 to Drive Extrafollicular Diffuse Large B-Cell Lymphoma

Dhanvantri Chahar, Abdessamad Alaoui Youssfi, Caroline Alice Coughlin, Hsuan-Ting Huang, Vivian L.S. Kuan, Venu Venkatarame Gowda Saralamma, Marianna Lekakis, Dylan Huynh, Francesco Maura, Catalina Amador, Daniel Bilbao Cortes, Jayanta Chaudhuri, Jonathan H Schatz

This study shows BCL10 gain-of-function mutations prevent naive B cells from entering germinal centers and cooperate with BCL6 to cause extrafollicular diffuse large B-cell lymphoma.

bioRxiv · Nov 5, 2026 · PreprintCancer Biology

Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity

Oriana Teran Pumar, Elton L VanNoy, Abigail Haffey, Durga Prasad Gannamedi, Christine Isabelle Rafie, Dylan Scott Lykke Harwood, Julia R. Benedetti, Christine Ann Pittman Ballard, Erika Ciervo, Pedro Henrique Assenza Tavares Coroa, Payal Grover, Brandon Emanuel León, Jonathan Mitchell, Asmita Pathak, Bruno Colon, , Defne Bayık

This study shows that DPP-4 inhibition improves CD8+ T cell metabolism and anti-tumor activity in preclinical and clinical settings.

bioRxiv · Apr 3, 2026 · PreprintImmunology

NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy

Paola Manara, Austin Daniel Newsam, Venu Venkatarame Gowda Saralamma, Tyler Andrew Cunningham, Drew Lazenby, J.J.David Ho, Marco Vincenzo Russo, Abdessamad Youssfi Alaoui, Dhanvantri Chahar, Alicia Bilbao Martinez, Nikolai S. Fattakhov, Alexandra Marie Carbone, Olivia Barbara Farag, Alexa Marie Barroso, Kyle S. Hoffman, , Jonathan Harry Schatz

This study shows that inhibiting cap-dependent translation in lymphoma cells increases sensitivity to ferroptosis and CAR-T therapy by reducing NRF2 expression.

Cancer Research · Jul 31, 2025Peer-reviewedCancer Biology

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant B-Cell Lymphoma

Austin Daniel Newsam, Bachisio Ziccheddu, Abdessamad A. Youssfi, Venu Venkatarame Gowda Saralamma, Yitzhar E. Goretsky, Isaiah Sheffield-Veney, Paola Manara, Daniel E Tsai, Adithi Jeevan, Santiago Foos-Russ, David M. Suissa, Marco Vincenzo Russo, Nikolai S. Fattakhov, David Carmona-Berrio, Natalia Campos Gallego, , Jonathan Harry Schatz

bioRxiv · Feb 27, 2025 · PreprintCancer Biology